The Enterprise Value as of November 2024 (TTM) for Oncotelic Therapeutics, Inc. (OTLC) is 25.10M

According to Oncotelic Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 25.10M. This represents a change of -5.59% compared to the average of 26.58M of the last 4 quarters.

Oncotelic Therapeutics, Inc. (OTLC) Historical Enterprise Value (quarterly & annually)

How has OTLC Enterprise Value performed in the past?

The mean historical Enterprise Value of Oncotelic Therapeutics, Inc. over the last ten years is 15.26M. The current 25.10M Enterprise Value has changed 16.35% with respect to the historical average. Over the past ten years (40 quarters), OTLC's Enterprise Value was at its highest in in the March 2022 quarter at 96.74M. The Enterprise Value was at its lowest in in the December 2015 quarter at -7110800.00.

Oncotelic Therapeutics, Inc. (OTLC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Oncotelic Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oncotelic Therapeutics, Inc. (OTLC) Average Enterprise Value

How has OTLC Enterprise Value performed in the past?

The current Enterprise Value of Oncotelic Therapeutics, Inc. (OTLC) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Oncotelic Therapeutics, Inc. (OTLC) Enterprise Value vs. Peers

How is OTLC’s Enterprise Value compared to its peers?

Oncotelic Therapeutics, Inc.’s Enterprise Value is greater than Ceapro Inc. (15.90M), greater than PhaseBio Pharmaceuticals, Inc. (-33955000.00), greater than Processa Pharmaceuticals, Inc. (831.36K), greater than Kaleido Biosciences, Inc. (4.26K), greater than Advanced Proteome Therapeutics Corporation (147.52K), less than Cellectis S.A. (144.28M), greater than ChitogenX Inc. (4.72M), greater than Biotron Limited (19.44M), less than Bioasis Technologies Inc. (39.52M), greater than Nascent Biotech, Inc. (9.49M), greater than ProtoKinetix, Incorporated (3.94M), greater than RespireRx Pharmaceuticals Inc. (2.94M), greater than Silo Pharma, Inc. (247.23K), greater than VG Life Sciences Inc. (4.22M), less than Rubius Therapeutics, Inc. (0), greater than Peak Bio, Inc. (-6254911.00), less than AlloVir, Inc. (0), greater than null (13.68M), greater than null (6.59M),

Build a custom stock screener for Oncotelic Therapeutics, Inc. (OTLC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncotelic Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncotelic Therapeutics, Inc. (OTLC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncotelic Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.